Mei‐Chih Liang - Concepedia

Author

Mei‐Chih Liang

Also Known As

Liang, Mei-Chih, M Liang, M-C Liang, M. Liang, Mei-Chi Liang, Mei-Chih Liang, Mei-chih Liang, Mei‐Chih Liang, Minhao Liang, Shimamura, Takeshi

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Harvard University Dana-Farber/Harvard Cancer Center Brigham and Women's Hospital Massachusetts General Hospital

About

Mei‐Chih Liang is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	3K
2	Engineering	2	2	67
3	Natural Sciences	2	2	71
4	Biochemistry	2	2	71
5	Public Health	1	1	266

Mei‐Chih Liang

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
LKB1 modulates lung cancer differentiation and metastasis Hongbin Ji, Matthew R. Ramsey, D. Neil Hayes, Nature MedicineLung Cancer DifferentiationCancer GeneticsCancer BiologyCell Biology	2007	1.1K
GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer Kenneth L. Scott, Omar Kabbarah, Mei‐Chih Liang, Nature Tumor BiologySignaling PathwayMedicineMtor SignallingTumor Suppressor	2009	349
Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition Anthony C. Faber, Danan Li, Young-Chul Song, Proceedings of the National Academy of Sciences ApoptosisCell DeathTumor BiologyOncologyReceptor Tyrosine Kinase	2009	317
Somatic LKB1 Mutations Promote Cervical Cancer Progression Shana N. Wingo, Teresa D. Gallardo, Esra A. Akbay, PLoS ONE Cervical Cancer ScreeningCervical Cancer ProgressionPrecancerous LesionsCervical CancerHuman Papillomavirus Vaccines	2009	266
An ErbB3 Antibody, MM-121, Is Active in Cancers with Ligand-Dependent Activation Birgit Schoeberl, Anthony C. Faber, Danan Li, Cancer Research Ligand-dependent ActivationChemoprevention StrategyImmunologyErbb3 AntibodyCancer Biology	2010	260
Characterization of the cell of origin for small cell lung cancer Mei‐Chih Liang, David M. Raiser, Raffaella Zamponi, Cell Cycle OncologyTumor MicroenvironmentOncogenic AgentMedicinePathology	2011	236
Bronchial and Peripheral Murine Lung Carcinomas Induced by T790M-L858R Mutant EGFR Respond to HKI-272 and Rapamycin Combination Therapy Danan Li, Takeshi Shimamura, Hongbin Ji, Cancer Cell Rapamycin Combination TherapyMedicineImmunologyPathologyBronchial Neoplasm	2007	234
Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models Hongbin Ji, Zhenxiong Wang, Samanthi A. Perera, Cancer Research	2007	176
Akt and mTOR mediate programmed necrosis in neurons Q Liu, Jianhua Qiu, Mei‐Chih Liang, Cell Death and Disease	2014	145
Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemia Aldo M. Roccaro, Antonio Sacco, Emanuel N. Husu, Blood	2009	99

Page 1